Arpa Garay - 28 Jun 2022 Form 3 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Commercial Officer
Signature
Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
28 Jun 2022
Net transactions value
$0
Form type
3
Filing time
29 Jun 2022, 16:04:42 UTC
Previous filing
05 May 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MRNA Stock Option (Right to Buy) 28 Jun 2022 Common Stock 34,766 $137.15 Direct F1
holding MRNA Restricted Stock Units 28 Jun 2022 Common Stock 18,248 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on June 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on June 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.